The history of Sildenafil presents a interesting case for investors in the drug sector. While initially a phenomenal success, generating huge profits, the exclusivity lapse and the subsequent entry of generic versions have drastically impacted income. This presents questions about the future sustainability of analogous therapeutic projects and s… Read More